TABLE 2.

Antifungal sensitivity of the five most common Candida species isolated from early failing VPs.

Species	Total number of isolates tested	Number of isolates in each category (%)
		Sensitive	Intermediate	Resistant
Fluconazole
Candida albicans	83	81 (97.6)	2 (2.4)	0
Candida glabrata	23	21 (91.3)	2 (8.7)	0
Candida tropicalis	15	15 (100)	0	0
Candida parapsilosis	14	12 (85.8)	0	2 (14.3)
Candida krusei	9	1 (11.1)	2 (22.2)	6 (66.7)
Total	144	130 (90.3)	6 (4.2)	8 (5.5)
Miconazole
Candida albicans	62	59 (95.1)	3 (4.9)	0
Candida glabrata	19	19 (100)	0	0
Candida tropicalis	13	7 (53.9)	6 (46.1)	0
Candida parapsilosis	9	4 (44.4)	4 (44.4)	1 (11.1)
Candida krusei	9	8 (88.9)	1 (11.1)	0
Total	112	97 (86.6)	14 (12.5)	1 (0.9)
Nystatin
Candida albicans	65	64 (98.5)	0	1 (1.6)
Candida glabrata	20	18 (90.0)	1 (5.0)	1 (5.0)
Candida tropicalis	15	15 (100)	0	0
Candida parapsilosis	9	9 (100)	0	0
Candida krusei	9	9 (100)	0	0
Total	118	115 (97.4)	1 (0.9)	2 (1.7)

The number of sensitive, intermediate, and resistant isolates based upon EUCAST breakpoint recommendations are given for the five most commonly isolated yeast species.